About Doctor
- Dr Adam Sharp is Leader of the Translational Therapeutics Team and Honorary Consultant Medical Oncologist within the Prostate Cancer Targeted Therapies Group and Drug Development Unit at The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research.
- Dr Sharp was awarded a Breast Cancer Campaign funded PhD studentship between 2002 and 2005, focusing on cancer drug discovery and development at the Cancer Research UK Clinical Research Unit (Southampton).
- Dr Sharp trained in London and achieved his Membership of the Royal College of Physicians (MRCP) in 2012.
- He obtained a position as a Specialist Registrar in Medical Oncology at the Royal Marsden Hospital NHS Foundation Trust in 2013.
- Dr Sharp has been supported as an Academic Clinical Lecturer (National Institute for Health Research) and more recently as a Clinical Research Training Fellow (Medical Research Council), allowing him to work with Professor de Bono and his team since 2015.
- He is focused on developing novel therapeutic strategies for the treatment of advanced prostate cancer and has published and presented work within this field.
- Dr Sharp's work has been recognized with research awards from the Royal Society of Medicine, Academy of Medical Sciences, and American Society of Clinical Oncology.
- He has been awarded a Prostate Cancer Foundation Young Investigator Award and Wellcome Trust Clinical Research Career Development Fellowship.
- The work of his team is focused on identifying novel therapeutic strategies to prevent the development of treatment resistance and to overcome the progression of cancer.
- He specialized in Advanced prostate cancer,New anti-cancer drugs,and Clinical trials
